- Home
- FOLD vs HI Comparison
FOLD vs HI Comparison
Compare FOLD & HI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOLD
- HI
- Stock Information
- Founded
- FOLD 2002
- HI 2007
- Country
- FOLD United States
- HI United States
- Employees
- FOLD N/A
- HI N/A
- Industry
- FOLD Biotechnology: Pharmaceutical Preparations
- HI Miscellaneous manufacturing industries
- Sector
- FOLD Health Care
- HI Consumer Discretionary
- Exchange
- FOLD Nasdaq
- HI Nasdaq
- Market Cap
- FOLD 2.8B
- HI 2.4B
- IPO Year
- FOLD 2007
- HI N/A
- Fundamental
- Price
- FOLD $9.58
- HI $35.13
- Analyst Decision
- FOLD Strong Buy
- HI Buy
- Analyst Count
- FOLD 8
- HI 2
- Target Price
- FOLD $17.00
- HI $36.50
- AVG Volume (30 Days)
- FOLD 2.1M
- HI 411.2K
- Earning Date
- FOLD 02-26-2025
- HI 02-03-2025
- Dividend Yield
- FOLD N/A
- HI 2.56%
- EPS Growth
- FOLD N/A
- HI N/A
- EPS
- FOLD N/A
- HI N/A
- Revenue
- FOLD $493,671,000.00
- HI $3,182,800,000.00
- Revenue This Year
- FOLD $34.33
- HI N/A
- Revenue Next Year
- FOLD $21.70
- HI $4.10
- P/E Ratio
- FOLD N/A
- HI N/A
- Revenue Growth
- FOLD 32.58
- HI 12.63
- 52 Week Low
- FOLD $8.79
- HI $25.11
- 52 Week High
- FOLD $14.03
- HI $50.58
- Technical
- Relative Strength Index (RSI)
- FOLD 50.06
- HI 72.79
- Support Level
- FOLD $8.79
- HI $30.25
- Resistance Level
- FOLD $9.63
- HI $31.79
- Average True Range (ATR)
- FOLD 0.29
- HI 0.86
- MACD
- FOLD 0.05
- HI 0.50
- Stochastic Oscillator
- FOLD 90.48
- HI 97.89
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.
About HI Hillenbrand Inc
Hillenbrand Inc is a U.S.-based company that operates through two segments. The Advanced Process Solutions segment designs, develops, manufactures, and services engineered industrial equipment. The Molding Technology Solutions segment offers engineered and customized systems in plastic technology and processing. It earns it revenue from Advanced Process Solutions, and Geographically from America, following by Asia and EMEA.